Next up was Aimee Sundberg & her talk on 'Assessment of discontinuations (DCs) and anti-cytomegalovirus (CMV) treatment (tx) switching in post-transplant refractory CMV infections with or without resistance (R/R): safety and sensitivity analyses from a Phase 3 randomized trial.'